glycerol has been researched along with danazol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Charman, WN; Cuiné, JF; Edwards, GA; Porter, CJ; Pouton, CW | 1 |
| Dalrymple, DM; Prajapati, HN; Serajuddin, AT | 1 |
1 trial(s) available for glycerol and danazol
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
3 other study(ies) available for glycerol and danazol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Danazol; Dogs; Drug Carriers; Drug Compounding; Emulsions; Estrogen Antagonists; Ethanol; Glycerides; Glycerol; Intestinal Absorption; Lipase; Lipids; Lipolysis; Male; Particle Size; Reproducibility of Results; Solubility; Solvents; Soybean Oil; Surface-Active Agents; Water | 2007 |
A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.
Topics: Chemistry, Pharmaceutical; Danazol; Diglycerides; Dosage Forms; Drug Delivery Systems; Emulsions; Fatty Acids; Glycerides; Glycerol; Monoglycerides; Particle Size; Solubility; Surface-Active Agents; Triglycerides; Water | 2012 |